Pharmaceuticals

GE Healthcare Life Sciences continues to invest in Uppsala. The company signs a two-year collaboration agreement with Uppsala BIO

Merck Serono is to establish a global R&D centre in Beijing, investing more than €150 million over the next four years.

The European Commission’s probe into suspected anti-trust activity in the pharmaceutical sector is rumbling on, with further dawn raids earlier this week.

The US pharma company Eli Lilly has launched a new model of open innovation devised to get over the drug industry’s productivity problems.

The Commission and the European Patent office are taking action to eradicate underhand tactics for keeping generic drugs off the market.

Cash-rich pharma is dropping any pretence they are buying cash-strapped biotech for access to innovative technology. What it wants is products. Let’s hope it doesn’t suffocate the feedstock of innovation in the process.